Spark Investment Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-33,769
Closed -$39K 92
2020
Q2
$39K Hold
33,769
0.14% 64
2020
Q1
$27K Sell
33,769
-24,131
-42% -$25.6K 0.01% 338
2019
Q4
$58K Sell
57,900
-4,300
-7% -$5.21K 0.01% 520
2019
Q3
$87K Sell
62,200
-4,500
-7% -$6.36K 0.01% 367
2019
Q2
$100K Sell
66,700
-28,300
-30% -$43.8K 0.01% 503
2019
Q1
$145K Buy
95,000
+30,600
+48% +$46.7K 0.01% 538
2018
Q4
$94K Buy
+64,400
New +$98.7K 0.01% 569
2018
Q3
Sell
-90,100
Closed -$165K 773
2018
Q2
$165K Buy
+90,100
New +$168K 0.01% 578
2017
Q4
Sell
-13,400
Closed -$15K 846
2017
Q3
$15K Sell
13,400
-47,400
-78% -$53.9K ﹤0.01% 704
2017
Q2
$78K Sell
60,800
-1,307
-2% -$1.85K ﹤0.01% 734
2017
Q1
$121K Sell
62,107
-18,393
-23% -$39K 0.01% 762
2016
Q4
$172K Buy
80,500
+58,500
+266% +$122K 0.01% 663
2016
Q3
$37K Buy
+22,000
New +$26.8K ﹤0.01% 794
2013
Q4
Sell
-11,400
Closed -$191K 721
2013
Q3
$191K Buy
+11,400
New +$160K 0.04% 453

Other funds holding MBII

Spark Investment Management's MBII Position: Q3 2020 in Review

Spark Investment Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2020, closing a stake of 33,769 shares — an estimated $39K sold.

Spark Investment Management first reported a position in MBII in Q3 2013 and held it in 14 quarters. The position peaked at $191K in Q3 2013. 58 funds tracked by Wall St. Rank hold MBII as of Q3 2020.

  • Spark Investment Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2020 after selling out during the quarter.
  • Spark Investment Management sold 33,769 Marrone Bio Innovations, Inc. shares in Q3 2020, an estimated $39K.
  • Spark Investment Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 14 quarters.
  • Spark Investment Management's Marrone Bio Innovations, Inc. position peaked at $191K in Q3 2013.
  • 58 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2020.

Based on Spark Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.